Alerts
Other content recommended for you
- The role of DAT-SPECT in movement disorders
- Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
- Present and future drug treatment for Parkinson’s disease
- [123I]β-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease
- Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?
- Dopamine transporter imaging with [123I]-β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson’s disease
- Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Initial management of Parkinson’s disease
- Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease